134 related articles for article (PubMed ID: 28375194)
1. Primary Breast Lymphoma with cutaneous involvement in a patient with Rheumatoid Arthritis - a complication of infliximab therapy?
Costa C; Aguiar R; Rodrigues M; Carvalho P; Ferreira J; Santiago M; Rito L; Silva J; Duarte C; da Silva J; Malcata A
Acta Reumatol Port; 2017; 42(2):191-195. PubMed ID: 28375194
[TBL] [Abstract][Full Text] [Related]
2. Primary cardiac B cell lymphoma: Manifestation of Felty's syndrome or TNFα antagonist.
Benzerdjeb N; Ameur F; Ikoli JF; Sevestre H
Pathol Res Pract; 2016 Dec; 212(12):1191-1193. PubMed ID: 27773517
[TBL] [Abstract][Full Text] [Related]
3. Diffuse large B-cell lymphoma in a patient with rheumatoid arthritis treated with infliximab and methotrexate.
Nakashima C; Tanioka M; Takahashi K; Miyachi Y
Clin Exp Dermatol; 2008 Jul; 33(4):437-9. PubMed ID: 18485021
[TBL] [Abstract][Full Text] [Related]
4. Breast lymphoma complicating anti-tumor necrosis factor therapy in rheumatoid arthritis.
Pattanaik D; Koduru S; Azouz A; Patil S; Carbone L
Clin Breast Cancer; 2011 Dec; 11(6):413-6. PubMed ID: 21729669
[TBL] [Abstract][Full Text] [Related]
5. Composite cutaneous lymphoma in a patient with rheumatoid arthritis treated with methotrexate.
Huwait H; Wang B; Shustik C; Michel RP
Am J Dermatopathol; 2010 Feb; 32(1):65-70. PubMed ID: 20098085
[TBL] [Abstract][Full Text] [Related]
6. Reactivation of Mycobacterium bovis infection and tumor necrosis factor inhibitors. A Mexican case.
Rodríguez-Orozco AR
Arch Bronconeumol; 2016 Jun; 52(6):336-7. PubMed ID: 26616568
[No Abstract] [Full Text] [Related]
7. [Cutaneous lymphoma associated with methotrexate in a patient with rheumatoid arthritis].
Antón Vázquez V; Corominas H; García Muñoz N; Hebe Petiti G
Farm Hosp; 2018 Jan; 42(1):35-36. PubMed ID: 29306316
[No Abstract] [Full Text] [Related]
8. Pneumocystis Jirovecii Pneumonia in Japanese Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor Inhibitors: A Pooled Analysis of 3 Agents.
Tanaka M; Sakai R; Koike R; Harigai M
J Rheumatol; 2015 Sep; 42(9):1726-8. PubMed ID: 26330129
[No Abstract] [Full Text] [Related]
9. Progressive multifocal leukoencephalopathy associated with infliximab.
Sammut L; Wallis D; Holroyd C
J R Coll Physicians Edinb; 2016 Sep; 46(3):163-165. PubMed ID: 27959350
[TBL] [Abstract][Full Text] [Related]
10. [Legionella pneumonia after infliximab in a patient with rheumatoid arthritis].
Giassi Kde S; Furlanetto V; Fialho S; Gomes Ribeiro G; Pereira IA
Rev Bras Reumatol; 2014; 54(5):397-9. PubMed ID: 25627305
[TBL] [Abstract][Full Text] [Related]
11. Primary cutaneous B cell lymphoma during methotrexate therapy for rheumatoid arthritis.
Fam AG; Perez-Ordonez B; Imrie K
J Rheumatol; 2000 Jun; 27(6):1546-9. PubMed ID: 10852288
[TBL] [Abstract][Full Text] [Related]
12. Unaffected reaction level in tuberculin skin test by long-term therapy with tumor necrosis factor inhibitors for rheumatoid arthritis.
Yamamoto S; Nagatani K; Sato T; Iwamoto M; Takatori S; Minota S
Int J Rheum Dis; 2017 May; 20(5):584-588. PubMed ID: 28524434
[TBL] [Abstract][Full Text] [Related]
13. [Unusual cutaneous angiofibromatosis following gold therapy of primary chronic polyarthritis].
Herbst WM; Hornstein OP; Griessmeyer G
Hautarzt; 1989 Sep; 40(9):568-72. PubMed ID: 2572572
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous T-cell lymphoma following treatment of rheumatoid arthritis with tumour necrosis factor-alpha blocking agents: two cases.
Lourari S; Prey S; Livideanu C; Jamard B; Lamant L; Cantagrel A; Paul C
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):967-8. PubMed ID: 19192017
[No Abstract] [Full Text] [Related]
15. Cutaneous gamma/delta T-cell lymphoma during treatment with etanercept for rheumatoid arthritis.
Koens L; Senff NJ; Vermeer MH; Ronday HK; Willemze R; Jansen PM
Acta Derm Venereol; 2009 Nov; 89(6):653-4. PubMed ID: 19997706
[No Abstract] [Full Text] [Related]
16. Direct Comparative Effectiveness Among 3 Anti-Tumor Necrosis Factor Biologics in a Real-Life Cohort of Patients With Rheumatoid Arthritis.
Santos-Moreno P; Sánchez G; Gómez D; Bello-Gualtero J; Castro C
J Clin Rheumatol; 2016 Mar; 22(2):57-62. PubMed ID: 26886438
[TBL] [Abstract][Full Text] [Related]
17. Segmental eruptive neurofibromatosis infliximab-induced.
Drago F; Pastorino C; Cecchi F; Parodi A
J Eur Acad Dermatol Venereol; 2016 Feb; 30(2):356-7. PubMed ID: 25352368
[No Abstract] [Full Text] [Related]
18. Rates of serious infections and malignancies among patients with rheumatoid arthritis receiving either tumor necrosis factor inhibitor or rituximab therapy.
Aaltonen KJ; Joensuu JT; Virkki L; Sokka T; Aronen P; Relas H; Valleala H; Rantalaiho V; Pirilä L; Puolakka K; Uusitalo T; Blom M; Konttinen YT; Nordström D
J Rheumatol; 2015 Mar; 42(3):372-8. PubMed ID: 25593230
[TBL] [Abstract][Full Text] [Related]
19. Characteristics and outcomes of rheumatoid arthritis patients who started biosimilar infliximab.
Sung YK; Cho SK; Kim D; Won S; Choi CB; Bang SY; Hong SJ; Kim HA; Koh EM; Lee HS; Suh CH; Yoo DH; Bae SC
Rheumatol Int; 2017 Jun; 37(6):1007-1014. PubMed ID: 28214924
[TBL] [Abstract][Full Text] [Related]
20. Spontaneous remission of marginal zone B cell lymphoma in a patient with seropositive rheumatoid arthritis after discontinuation of infliximab-methotrexate treatment.
Thonhofer R; Gaugg M; Kriessmayr M; Neumann HJ; Erlacher L
Ann Rheum Dis; 2005 Jul; 64(7):1098-9. PubMed ID: 15958773
[No Abstract] [Full Text] [Related]
[Next] [New Search]
